Neurology
2 drugs are in development for Myotonic Dystrophy Type 1 (DM1).
- Companies
- 2
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Myotonic Dystrophy Type 1 (DM1) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| DYNE-101 | Dyne Therapeutics, Inc. (DYN) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| vx-670 | Entrada Therapeutics, Inc. (TRDA) |
About this indication
Myotonic Dystrophy Type 1 (DM1) context
Neurology·MeSH: Myotonic Dystrophy (D009223)
Narrower concept of MeSH descriptor Myotonic Dystrophy 1
Frequently asked questions
How many drugs are in development for Myotonic Dystrophy Type 1 (DM1)?
BioSniper tracks 2 drugs in development for Myotonic Dystrophy Type 1 (DM1) across 2 companies.
How many clinical trials target Myotonic Dystrophy Type 1 (DM1)?
There are 6 clinical trials targeting Myotonic Dystrophy Type 1 (DM1) tracked by BioSniper.